Zumutor Biologics
PrivateLast Round
Series B
Jun 15, 2026
Est. Valuation
$36.2M
Total Funding Raised
$27.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Zumutor Biologics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in June 2026.
Zumutor Biologics is a biotechnology company that develops targeted NK cell therapeutics and high-diversity human antibody libraries to discover innovative immunotherapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zumutor Biologics Comparables
Compare Zumutor Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou DAC Biotechnology Co., Ltd. | 80% | |
| Immunitas Therapeutics | 78% | |
| AbCellera Biologics Inc. | 69% |
For institutional investors. Book with your work email.
Zumutor Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 15, 2026 | ||||
| Series A Extension | Dec 10, 2021 | ||||
| Grant | Sep 7, 2020 | ||||
| Series A Extension | Nov 1, 2019 | ||||
| VC Round | Apr 1, 2018 | ||||
Seed | Oct 11, 2013 |
For institutional investors. Book with your work email.
Zumutor Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Karnataka Information Technology Venture Fund | Seed, Series A |
| Bharat Innovation Fund | Series A Extension, Series B |
| Aarin Capital Partners | Seed, Series A |
| Premji Invest | Series B |
| Siana Capital Management | Series A Extension |
| Chiratae Ventures | Seed, Series A |
| Accel | Series A Extension, Seed, Series A, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 119% MoM, reaching 6.7K.
- Jun 15, 2026
$7.3M raised led by Accel and Bharat Innovation Fund.
For institutional investors. Book with your work email.
Zumutor Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zumutor Biologics's valuation, stock price, and market status.
Is Zumutor Biologics a public or private company?
Zumutor Biologics is a private company.
What is the current stock price of Zumutor Biologics?
Zumutor Biologics is a private company, so its shares have no public market price. Caplight tracks Zumutor Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zumutor Biologics worth (valuation)?
Zumutor Biologics's valuation is estimated at $36.2M based on funding round data.
Can I buy Zumutor Biologics stock?
Zumutor Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zumutor Biologics's last funding round?
Zumutor Biologics's most recent funding round was Series B on June 15, 2026.
Who are the main investors in Zumutor Biologics?
Key investors in Zumutor Biologics include Bharat Innovation Fund, Siana Capital Management, Accel.
Will Zumutor Biologics IPO soon?
No public IPO plans have been announced for Zumutor Biologics.
How can I track Zumutor Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Zumutor Biologics's shares on secondary markets.